COMPANY
Pace Pharmaceuticals, Inc.
Pace Pharmaceuticals uses AI and lab robotics to discover small-molecule drugs for neurological disease, led by PAC-832 for Alzheimer's. Source · checked Oct 14, 2026
Sourced facts
Funding (SEC filing)
- SEC Form D filed Sep 28, 2026: $50,000 sold · sec.gov · checked Oct 14, 2026
Funding and NIH signals
- SEC Form D raise Raised $50K (Form D filed Sep 28, 2026). SEC Form D 0002157304-26-000001 (Sep 28, 2026)
Evidence (1 event)
- Sep 28, 2026 · SEC Form D 0002157304-26-000001
Name of Issuer: Pace Pharmaceuticals, Inc.; CIK: 2157304; Address: Cupertino, CA; Submission type: D; Filing date: 2026-09-28; Industry Group: Biotechnology; Date of First Sale: 2026-09-18; Types of Securities Offered: Other (Simple Agreement for Future Equity); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 50000; Federal exemptions: 06c
- Sep 28, 2026 · SEC Form D 0002157304-26-000001